Michael Ross
Directeur/Membre du Conseil chez 20/20 GENESYSTEMS INC.
Profil
Michael A.
Ross is currently the Director at 20 and Operating Partner at Havencrest Capital Management LLC.
He is also a Board Member at LarreaRX, Inc. In the past, he served as the President & CEO of Euclid Vision Corp., President and COO of E-P Therapeutics, Inc., and President of CPL, Inc. Dr. Ross received his undergraduate degree from Dickinson College in 1971 and his doctorate from George Washington University School of Medicine & Health in 1975.
Postes actifs de Michael Ross
| Sociétés | Poste | Début |
|---|---|---|
| 20/20 GENESYSTEMS INC. | Directeur/Membre du Conseil | 01/07/2016 |
Havencrest Capital Management LLC
 Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Private Equity Investor | 01/04/2020 |
LarreaRX, Inc.
 LarreaRX, Inc. Pharmaceuticals: MajorHealth Technology Part of Larrea Biosciences Corp., LarreaRX, Inc. produces and distributes dietary supplements, cold sore lotions, and penetrating sprays. The company is based in Casper, WY. The company was founded by David Timothy Kalenuik. LarreaRX was acquired by Larrea Biosciences Corp. on September 24, 2004. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Ross
| Sociétés | Poste | Fin |
|---|---|---|
| E-P Therapeutics, Inc. | President | 01/01/2015 |
CPL, Inc.
 CPL, Inc. Pharmaceuticals: MajorHealth Technology CPL, Inc. manufactures pharmaceutical ingredients. Its products include Alendronate Sodium, Amlodipine Besylate, Atomoxetine Hydrochloride, Bosentan, Celecoxib, Chlorhexidine Base and Desloratadine. The company was founded in 1999 and is headquartered in Washington, DC. | President | 01/10/2009 |
Euclid Vision Corp.
 Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | President | - |
Euclid Vision Corp.
Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | Directeur Général | - |
Formation de Michael Ross
| George Washington University School of Medicine & Health | Doctorate Degree |
| Dickinson College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Euclid Vision Corp.
Euclid Vision Corp. Medical SpecialtiesHealth Technology Euclid Systems Corp. provides eye care technology and services. It offers ophthalmic equipment, therapeutics, devices, and lenses. The company was founded in 1995 and is headquartered in Sterling, VA. | Health Technology |
20/20 GeneSystems, Inc.
 20/20 GeneSystems, Inc. Medical/Nursing ServicesHealth Services 20/20 GeneSystems, Inc. develops and commercializes proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in 2000 and is headquartered in Rockville, MD. | Health Services |
Havencrest Capital Management LLC
Havencrest Capital Management LLC Investment ManagersFinance Havencrest Capital Management LLC (Havencrest Capital) is a private equity firm founded in 2017 by Christopher W. Kersey. The firm is headquartered in Dallas, Texas. | Finance |
LarreaRX, Inc.
LarreaRX, Inc. Pharmaceuticals: MajorHealth Technology Part of Larrea Biosciences Corp., LarreaRX, Inc. produces and distributes dietary supplements, cold sore lotions, and penetrating sprays. The company is based in Casper, WY. The company was founded by David Timothy Kalenuik. LarreaRX was acquired by Larrea Biosciences Corp. on September 24, 2004. | Health Technology |
| E-P Therapeutics, Inc. | |
CPL, Inc.
CPL, Inc. Pharmaceuticals: MajorHealth Technology CPL, Inc. manufactures pharmaceutical ingredients. Its products include Alendronate Sodium, Amlodipine Besylate, Atomoxetine Hydrochloride, Bosentan, Celecoxib, Chlorhexidine Base and Desloratadine. The company was founded in 1999 and is headquartered in Washington, DC. | Health Technology |